PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-644

Interestingly he also told us in that presentation they are already talking to big pharma. It was regarding the AD,PD pre clinical work, it went something like this. " There are several models we can use so we have discussed with Big Pharma what they want to see" [Rough translation]

I guess it's possible that's all they discussed. But I think it unlikely, it's much more likely both parties would be keen to discuss the whole package. Keeping in mind discussions are not negotiations. But one leads to the other.

Disclaimer; I'm not saying we will get an offer tomorrow, I really have no idea. But it is possible, and will be influenced by may things on the BP side like their risk aversion and confidence in MPL. But the longer they wait, the more they will pay, while risking another company slipping in under their guard.

Cheers